Lymphoma & Myeloma has ended

Create Your Own Event

Lymphoma & Myeloma

10:50am PDT

Diagnosis and treatment of newly diagnosed ALL Empire Ballroom EastPinkal Desai, MD

11:10am PDT

Immunotherapy of ALL Empire Ballroom EastPinkal Desai, MD

11:30am PDT

Which patients should be transplanted for ALL? Empire Ballroom EastKoen vanBesien, MD, PhD

12:00pm PDT

Panel discussion and post-session audience survey Empire Ballroom East

1:45pm PDT

Session II: MPN & MDS Empire Ballroom EastGail Roboz, MD

1:46pm PDT

Pre-session audience survey Empire Ballroom East

1:55pm PDT

Monitoring patients on longstanding TKI therapy for CML: What to look for other than BCR-ABL Empire Ballroom EastEllen Ritchie, MD

2:15pm PDT

Treatment strategies for myelofibrosis Empire Ballroom EastEllen Ritchie, MD

2:35pm PDT

MDS: Is your hypomethylator working? Empire Ballroom EastSangmin Lee, MD

2:55pm PDT

Which patients with CML should stop TKI therapy? Empire Ballroom EastEllen Ritchie, MD

3:25pm PDT

Panel discussion and post-session audience survey Empire Ballroom East

4:00pm PDT

Session III: Special Topics (Part of this session is supported by an unrestricted educational grant through AbbVie, Inc.) Empire Ballroom EastGail Roboz, MD

4:01pm PDT

Pre-session audience survey Empire Ballroom East

4:10pm PDT

Newly diagnosed AML: Hitting the right target Empire Ballroom EastGail Roboz, MD

4:30pm PDT

AML: What to do with your 500-gene mutation report Empire Ballroom EastSangmin Lee, MD

4:50pm PDT

MRD in AML: What is it and what do I do about it? Empire Ballroom EastGail Roboz, MD

5:10pm PDT

AML 60-80 years: Who should get an allo transplant? Empire Ballroom EastKoen vanBesien, MD, PhD

5:30pm PDT

Panel discussion and post-session audience survey Empire Ballroom East